The weekly litigation news digest is live. Subscribe now

IP Verse

Combination Therapies For Cancer - EP3003316

The patent EP3003316 was granted to Glaxosmithkline on Jul 22, 2020. The application was originally filed on May 28, 2014 under application number EP14805105A. The patent is currently recorded with a legal status of "Revoked".

EP3003316

GLAXOSMITHKLINE
Application Number
EP14805105A
Filing Date
May 28, 2014
Status
Revoked
Jun 2, 2023
Publication Date
Jul 22, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

PAJAROApr 21, 2021ALTADMISSIBLE

Patent Citations (4) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTUS2012196879
INTERNATIONAL-SEARCH-REPORTWO2013019906
OPPOSITIONUS10010608
OPPOSITIONWO2014193898

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents